This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...